BGPharma discussion on Generic Industry in our country and its key importance for the Bulgarian industry has started

We are witnessing a policy change in the field of healthcare and absence of consensus for its strategic development. This is detrimental to patients such as we all are at one time or another.

The appeal of BHPharma is to develop and follow a policy to guarantee us that there will be someone to treat us in Bulgaria, and treat us adequately at that.

Principles are necessary to unite all – political forces, industry and patients, and to work in one direction. When this happens and experts have been found to create a financial framework for this strategy, then we will be witnesses to the stabilisation and improvement of the healthcare sector in our country.